Proteintech acquires ChromoTek

By The Science Advisory Board staff writers

October 20, 2020 -- Proteintech, a German-based producer of antibodies, proteins, and immunoassays, has acquired ChromoTek, a manufacturer of camelid single-domain antibodies (aka nanobodies).

ChromoTek produces the nanobodies with high-performance recombinant reagents. Combined with Proteintech, the companies will address growing opportunities in single-cell analysis, super-resolution imaging, and multiplex assays.

Proteintech has a large portfolio of self-manufactured antibodies covering two-thirds of the human proteome. The company also offers cytokines, growth factors, and other human-expressed proteins.

Financial details were not disclosed.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.